Deubiquitylating (DUB) Enzyme Targeting for Treatment of Human Disease

Time: 2:00 pm
day: Day One

Details:

  • DUBs antagonize action of ubiquitin ligases – inhibiting the inhibitor
  • DUB specificity/localisation informs target/indication selection – USP30 as an example
  • DUB opportunities exist in neurodegenerative disease

Speakers: